Clinical Trial Update: A Study to Evaluate the Neuro-embolic Consequences of TAVR

View source ↗

Summary

Completion of a clinical trial evaluating neuro-embolic outcomes after transcatheter aortic valve replacement (TAVR) in patients with aortic valve stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Snippet

Sponsor: Keystone Heart | Conditions: Aortic Valve Stenosis | Status: COMPLETED